Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)

EURopean Trial Reduction Cardiac E, KM Fox, M Bertrand, R Ferrari, WJ Remme, ML Simoons, WJ Remme, M Simoons, JP Bassand, J Aldershvile, P Hildebrandt, M Bertrand, D Cokkinos, P Toutouzas, J Eha, L Erhardt, J Erikssen, P Grybauskas, U Kalnins, K KarschU Sechtem, M Keltai, W Klein, T Luscher, D Mulcahy, M Nieminen, A Oto, O Ozsaruhan, W Paulus, L Providencia, [No Value] Riecansky, W Ruzyllo, R Ferrari, U Santini, L Tavazzi, J Soler-Soler, P Widimsky, KM Fox, D Julian, H Dargie, G Murray, W Kubler, K Thygesen, D Duprez, G Steg, H Drexel, G Gombotz, W Klein, D Duprez, GH Heyndrickx, Lisa Legrand

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology